• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Clin Pract . Venous thromboembolism is linked to severity of disease in COVID-19 patients: A systematic literature review and exploratory met

tetano

Editor, Senior Moderator
Int J Clin Pract


. 2021 Sep 22;e14910.
doi: 10.1111/ijcp.14910. Online ahead of print.
Venous thromboembolism is linked to severity of disease in COVID-19 patients: A systematic literature review and exploratory meta-analysis


Rashmi Srivastava[SUP] 1 [/SUP], Rizwana Parveen[SUP] 1 [/SUP], Pinki Mishra[SUP] 1 [/SUP], Nilanjan Saha[SUP] 1 [/SUP], Ram Bajpai[SUP] 2 [/SUP], Nidhi Bharal Agarwal[SUP] 1 [/SUP]



Affiliations

Abstract

Purpose: Coronavirus disease-2019 (COVID-19) may predispose to venous thromboembolism (VTE) and arterial thromboembolism due to excessive inflammation, hypoxia, immobilization and diffuse intravascular coagulation. The understanding of the association might be helpful in early vigilant monitoring and better management of COVID-19 patients at a high risk. Thus, in this meta-analysis we aim to assess the association of venous thromboembolism with severity of COVID-19 disease.
Methods: A literature search was conducted on PubMed and Cochrane Central Register of Controlled Trials using the keywords "COVID-19 and thromboembolism" and "COVID-19 and embolism", till 20 February 2021. Thirteen studies including 6648 COVID-19 patients were incorporated in this systematic review and exploratory meta- analysis.
Results: The analysis revealed nearly three times more risk of intensive care unit (ICU) care in patients with venous thromboembolism (VTE) compared to non-VTE patients (RR: 2.78; 95% CI: 1.75- 4.39; p <0.001; I[SUP]2[/SUP] : 65.1 %). Patients with pulmonary embolism and deep vein thrombosis are at increased risk of being admitted to ICU (RR: 2.21; 95% CI: 1.86-2.61; p<0.001; I[SUP]2[/SUP] :41.2%) and (RR: 2.69; 95 % CI: 2.37-3.06; p <0.001; I[SUP]2[/SUP] : 0.0 %), respectively. The quality assessment indicated that the included studies were of fair quality.
Conclusions: Our findings suggest that venous thromboembolism either deep vein thrombosis or pulmonary embolism may have a negative effect on the health status of COVID-19 patients. The study highlights the need to consider measures for reducing thromboembolism risk among COVID-19 patients.

Keywords: COVID-19; SARS-CoV-2; deep vein thrombosis; pulmonary embolism; venous thromboembolism.
 
Back
Top Bottom